Public demo on a synthetic test scenario: SUP-A001 (AsiaTech Mouldings, Vietnam, PP injection). Replace this with your real ERP + contract data on a paid pilot. Every number on this page is source-tagged per the Data-Integrity Charter. Ask AkunAI below is live — your question goes through our server, no key needed.
Their ask
+7.0%
letter · actual
Defensible (index)
+4.7%
Tecnon PP + Vietnam labour + Brent
Buyer's room
2.3 pp
computed
Akuna spend / yr
€30.6M
master file · actual
Share of supplier
14%
master file · actual
🎙
Ask AkunAI
Conversational coach — sourced, 2-3 sentences
What's my opening line?If they refuse to share CBD, what's plan B?Draft me a sharper response emailWhat's the strongest argument for the meeting?Walk me through the chess plan in 30 secondsHelp me handle 'this is non-negotiable'
Headline
Supplier AsiaTech Mouldings (Vietnam, PP injection) notified +7% citing labour. Index reading supports +4.7%. Buyer's room is 2.3 percentage points. Asymmetry favours us: we're 14% of their revenue, they're dual-sourced, alt panel exists.
Strategy verdict: STRENGTH. Anchor low, frame around CBD obligation breach, offer multi-year only as fallback.
Three opening moves
Anchor at 0% — supplier failed to share the CBD required by Art 7.6. contract
Target +4.7% with a quarterly index-linked review. index
Fallback +5.85% only if supplier commits to 24-month volume protection. prior band
Opening line — verbatim
"Before we discuss any number, AsiaTech Mouldings — can you walk us through the cost-breakdown that supports this notice? Article 7.6 of our agreement requires it."
Closing line — verbatim
"We will come back to you within five working days. Please confirm in writing the cost drivers and the percentage of the CBD they affect."
Risks & gaps
CBD never received. Without it, every cost-line argument is bounded — but the absence itself is a leverage point under Art 7.6.
Live web research currently stubbed. Power-map names are placeholder; swap to Apollo/LinkedIn before high-stakes meetings. stub_v1
Should-price reconstruction
For the highest-volume part. Index moves cited per cost line, weighted by CBD share (industry priors).
Cost line
Weight
Index
Δ since last fix
Weighted
Raw material
55%
Tecnon Orbichem PP NWE stub
+3.5%
+1.95%
Labour
18%
World Bank LMI Vietnam index
+2.5%
+0.46%
Energy
7%
EIA Brent index
−3.5%
−0.25%
Overhead + margin
20%
—
0
0
Defensible total
+4.72%
Live scenario sliders
Drag to flex the negotiated %, volume, or index assumption. Annual EUR impact recomputes.
4.7%
0%
3.5%
Annual EBIT impact: —
Compared to accepting their +7%: — avoided
Retro pass-through — the asymmetric argument
€108,030 retro credit detected. Resin index dropped 25.81% in October 2023 vs contract sign — supplier kept the gain. Use this to anchor: "we are owed before any forward increase." index
Method: walk the index time series from contract sign (2022-09) to today. Identify months where the index dropped > 3% vs sign. For each, compute the implied should-price decrease at that month, weighted by CBD raw-material share × monthly volume × nominated unit price.
Negotiation use
"We've reviewed the index history since contract sign. Between October 2023 and February 2024 your raw-material index dropped between 21 and 26 percent below the level at which we agreed the price. None of that movement was passed through. We estimate the unrealised credit at ~€108,000 over the contract life. Before any forward increase is discussed, we'd like to align on how that credit is recognised."
● Supplier obligation present — they have not delivered → breach
Price revision
● Anniversary-linked clause referenced
Change of control
● Standard wording
Exclusivity
● Limited — non-exclusive on Akuna side
Payment terms
● Net 30 — possible lever
Clauses NOT found (potential gaps)
Termination for convenience · Force majeure scope · Audit rights · Most-favoured-customer · Auto-renewal · Minimum volume · Lead-time. Contract Specialist needs deeper read.
External benchmark — alt-supplier panel
7 alt-suppliers across the plastics-injection family in our base. Used as credible-threat anchor.
ID
Supplier
Country
Avg €/unit
Δ vs SUP-A001
SUP-A006
Eurotec Plastics
Austria
€4.10
−65%
SUP-A007
Alpine Components
France
€7.29
−38%
SUP-A008
Autoplast Italia
Italy
€8.35
−29%
SUP-A009
Baltika Mouldings
Latvia
€8.50
−28%
SUP-A004
DynaPoly Solutions
Germany
€9.25
−22%
Switch verdict: credible_partial_threat. Switch score 2.8/5. Use as background pressure in Round 1, anchor in Round 2.
Internal benchmark — what we already pay elsewhere
Best-line in meeting: "We already pay €1.56 per unit for 'PP/EPDM bracket, injection-moulded' at NorthSea Injection (SUP-A005, Sweden) — 90% below the price you charge for PP-housing-001-006." master file
Sanity checks (auto-fired)
5 mathematical checks on the supplier's claim. 4 of 5 fired with leverage findings.
🎯Off-cycle request — 105 days from contract anniversary. Cite the price-revision article and reject on procedural grounds.
🎯Productivity glide-path NOT delivered — industry norm −2.5%/yr would put price at €14.04; actual €14.67, gap +4.5%.
🎯CBD math doesn't work — claim 7.0% overshoots the plausible envelope by 4.1pp. Cited drivers support only +2.9%.
🎯Cherry-picked indices — supplier cited labour + raw_material but omitted energy, which moved in our favour.
ℹMargin envelope OK — implied margin uplift is 1.4pp, within industry range.
Power map
Live LinkedIn / Apollo data not yet wired. Names below are stub-v1.
Supplier side
Phan T.
VP Sales EMEA · 4 yrs · neutral
Linh N.
CEO · 11 yrs · owner-driven, value-conscious
Tran Q.
Head of Operations · 8 yrs · deliveries-first
Akuna side
Romeo R.
Procurement Director · owner
Plant Director
Internal customer · hates supply disruption
CFO
Approver · watches EBIT
Risk & walk-away
Walk-away cost
€400,000 one-off
Tooling €180k + PPAP €220k
Pays back at
1.31%
rejected increase / 12 months
Lead-time
6 months
to qualify alt supplier
Six concession levers — concrete trade-offs
1 · Payment terms (Net 30 → Net 60)
Akuna captures €201,280 / yr in working-capital saving (8% WACC).
2 · Volume re-commitment (+15% over 24 months)
Extra spend offered: €4,591,708
3 · FX share-back (EUR/VND +3.5% since 2024)
Implied supplier saving: €321,420 / yr
stub_v1 — verify live before citing
4 · Tariff / regulatory (EU-Vietnam FTA)
EU-Vietnam free trade reduces import tariffs to 0% on most plastics by end-2026.
stub_v1
5 · Multi-year extension (+2 years)
Offer continuity in exchange for: freeze + −2%/yr productivity glide-path written in + most-favoured-customer language.
6 · Cash on delivery (1.5% discount)
Akuna saves €459,171 / yr at full pre-payment.
RFI ready to send
A draft RFI addressed to the top 5 alternative suppliers — ready to attach in your next email.
Recipients (top 5 from panel)
Supplier
Country
Eurotec Plastics (SUP-A006)
Austria
Alpine Components (SUP-A007)
France
Autoplast Italia (SUP-A008)
Italy
Baltika Mouldings (SUP-A009)
Latvia
DynaPoly Solutions (SUP-A004)
Germany
In production: one-click "Send via my inbox" with OAuth, or download as .docx.
Chess plan — three plies ahead
Opening · supplier's three likely responses · our counter for each · projected end-state. Walk-away thresholds declared before move 1.
Move 1 — Us
"Before we discuss any number, can you walk us through the cost-breakdown that supports this notice? Article 7.6 of our agreement requires it."
Their reply A — likely high
"We can't share the full CBD — it's commercially sensitive. But here are the key drivers: resin and labour."
Counter A
"Then we cannot evaluate. The contract obligates disclosure of cost drivers and proportion of CBD they affect. Until that lands, our position is unchanged."
End-state A
Supplier shares a redacted CBD within 5 days. We re-anchor at +3-4%.
Their reply B — likely medium
"Take it or leave it — non-negotiable; effective Apr 15."
Counter B
Pause. "Help me understand what specifically is non-negotiable — the percentage, the timing, or the scope?" Bounce, don't argue. Escalate to supplier's CEO via the customer-of-record relationship.
End-state B
CEO softens. We close at +4-5% with a 12-month freeze.
Their reply C — likely low
"Withdrawing the increase, but raising lead-time / reducing capacity allocation."
Counter C
Activate dual-source on top 3 SKUs immediately. Move 40% of volume to alt panel within 8 weeks.
End-state C
Supplier walks back the capacity threat within 2 weeks once they see PO shifting.
Walk-away thresholds (declared NOW, before any meeting)
Hard ceiling: +5.5% / 12-month validity. Above that, we pivot to dual-source.
Procedural floor: no agreement without a CBD or written index citation.
Time-cap: 3 rounds. If no convergence, RFI goes out and we run a 4-week sourcing exercise.
